Inventor · disambiguated record
Jim Swildens
Also filed as: SWILDENS JIM
1 granted patent·6 pending applications·0 citations·filing 2015–2021
12Inventor score
Technology areasC12N
Top patents by PatentIndex Score
7 records- 0152US12398393B2RNA-editing oligonucleotides for the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2020·Granted Aug 26, 2025·0 cites·15 claims
- 0250US2023039928A1Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt diseasePROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 0348US2023134677A1Antisense oligonucleotides for use in the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2021·Application pending·0 cites
- 0444US2022213478A1Antisense oligonucleotides for the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 0540US2022098584A1Antisense oligonucleotides for the treatment of leber`s congenital amaurosisPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
- 0637US2022127610A1Oligonucleotides for use in the treatment of dystrophic epidermolysis bullosaPHOENICIS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0721US2017327821A1Oligonucleotides for genomic dna editingPROQR THERAPEUTICS II BV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jim Swildens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →